SEC Form 4 · accession 0001437749-15-021227
RESPONSE BIOMEDICAL CORP · RBM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J. Adams
Officer — CFO & Corporate Secretary
Period of report
Nov 17, 2015
Accepted (ET)
Nov 19, 2015 · 5:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806888
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Nov 17, 2015 | P | 15,600 | $0.6395 | A | 31,700 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Price shown is denominated in Canadian Dollars
- F2Represents the weighted average share price of an aggregate total of 15,600 shares purchased in the price range of $0.50 to $0.66 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares acquired at each separate price.
- F3Shares held directly by RBC Dominion Securities Inc. in Trust for William Adams RRSP, for the benefit of the Reporting Person, for which the Reporting Person is the sole beneficial owner.